CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation

Vaccine

Volumn 28, Issue 2, 2009, Pages 422-429

  Ahmed, Tanvir ^a,b   Arifuzzaman, Mohammad ^a   Lebens, Michael ^b   Qadri, Firdausi ^a   Lundgren, Anna ^b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

FASCIA; Oral cholera vaccine; T cell response; Young children; Zinc supplementation

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; GAMMA INTERFERON; GANGLIOSIDE GM1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; ZINC ACETATE;

ANTIBODY RESPONSE; ARTICLE; BANGLADESH; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CHILD; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG FEVER; DRUG POTENTIATION; DRUG PROTEIN BINDING; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INFANT; INTERFERON PRODUCTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VACCINATION; VITAMIN SUPPLEMENTATION; VOMITING;

ADMINISTRATION, ORAL; ANTIBODY FORMATION; BANGLADESH; CD4-POSITIVE T-LYMPHOCYTES; CHOLERA; CHOLERA VACCINES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT; MALE; VACCINES, INACTIVATED; ZINC;

EID: 70849136304     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.032     Document Type: Article

References (51)

1. Clemens J.D., Sack D.A., Harris J.R., Van Loon F., Chakraborty J., Ahmed F., et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335 8684 (1990 Feb 3) 270-273
2. Lopez A.L., Clemens J.D., Deen J., and Jodar L. Cholera vaccines for the developing world. Human vaccines 4 March-April (2) (2008) 165-169
3. Qadri F., Ahmed T., Wahed M.A., Ahmed F., Bhuiyan N.A., Rahman A.S., et al. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine. Vaccine 22 January (3-4) (2004) 416-421
4. Qadri F., Mohi G., Hossain J., Azim T., Khan A.M., Salam M.A., et al. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol 2 November (6) (1995) 685-688
5. Svennerholm A.M., Jertborn M., Gothefors L., Karim A.M., Sack D.A., and Holmgren J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis 149 June (6) (1984) 884-893
6. Albert M.J., Qadri F., Wahed M.A., Ahmed T., Rahman A.S., Ahmed F., et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis 187 March (6) (2003) 909-913
7. Jertborn M., Svennerholm A.M., and Holmgren J. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 10 2 (1992) 130-132
8. Hornqvist E., Goldschmidt T.J., Holmdahl R., and Lycke N. Host defense against cholera toxin is strongly CD4+ T cell dependent. Infect Immun 59 October (10) (1991) 3630-3638
9. Castello-Branco L.R., Griffin G.E., Poulton T.A., Dougan G., and Lewis D.J. Characterization of the circulating T-cell response after oral immunization of human volunteers with cholera toxin B subunit. Vaccine 12 January (1) (1994) 65-72
10. Ahmed T., Svennerholm A.M., Tarique A.A., Sultana G.N., and Qadri F. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine 27 February (9) (2009) 1433-1439
11. Gans H.A., Arvin A.M., Galinus J., Logan L., DeHovitz R., and Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280 August (6) (1998) 527-532
12. Upham J.W., Rate A., Rowe J., Kusel M., Sly P.D., and Holt P.G. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect Immun 74 February (2) (2006) 1106-1112
13. Zinkernagel R.M., and Hengartner H. Regulation of the immune response by antigen. Science 293 July (5528) (2001) 251-253
14. Linhares A.C., Lanata C.F., Hausdorff W.P., Gabbay Y.B., and Black R.E. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea. Pediatr Infect Dis J 18 November (11) (1999) 1001-1006
15. Rennels M.B. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 174 September (Suppl. 1) (1996) S107-S111
16. Sack D., Qadri F., and Svennerholm A.M. Determinants of responses to oral vaccines in developing countries. In: Hernell O. (Ed). Annales Nestle (2008), Karger, Umea 71-79
17. Rink L., and Haase H. Zinc homeostasis and immunity. Trends Immunol 28 January (1) (2007) 1-4
18. Wellinghausen N., Kirchner H., and Rink L. The immunobiology of zinc. Immunol Today 18 November (11) (1997) 519-521
19. Qadri F., Ahmed T., Ahmed F., Begum Y.A., Sack D.A., and Svennerholm A.M. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups. Vaccine 24 March (10) (2006) 1726-1733
20. Svahn A., Linde A., Thorstensson R., Karlen K., Andersson L., and Gaines H. Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J Immunol Methods 277 June (1-2) (2003) 17-25
21. Lundin B.S., Johansson C., and Svennerholm A.M. Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4+ and CD8+ T cells in humans. Infect Immun 70 October (10) (2002) 5622-5627
22. Jobling M.G., and Holmes R.K. Analysis of structure and function of the B subunit of cholera toxin by the use of site-directed mutagenesis. Mol Microbiol 5 July (7) (1991) 1755-1767
23. Sanchez J., and Holmgren J. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci USA 86 January (2) (1989) 481-485
24. Lebens M., Johansson S., Osek J., Lindblad M., and Holmgren J. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines. Biotechnology (Nature Publishing Company) 11 December (13) (1993) 1574-1578
25. Helmuth R., and Achtman M. Cell-cell interactions in conjugating Escherichia coli: purification of F pili with biological activity. Proc Natl Acad Sci USA 75 3 (1978 Mar) 1237-1241
26. Qadri F., Wenneras C., Albert M.J., Hossain J., Mannoor K., Begum Y.A., et al. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun 65 September (9) (1997) 3571-3576
27. Westphal O., Jann K., and Himmelspach K. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog Allergy 33 (1983) 9-39
28. Bhuiyan T.R., Lundin S.B., Khan A.I., Lundgren A., Harris J.B., Calderwood S.B., et al. Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation. Infect Immun 77 May (5) (2009) 1888-1893
29. Hotz C., Lowe N.M., Araya M., and Brown K.H. Assessment of the trace element status of individuals and populations: the example of zinc and copper. J Nutr 133 May (5 Suppl. 1) (2003) 1563S-1568S
30. Smith Jr. J.C., Butrimovitz G.P., and Purdy W.C. Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clin Chem 25 August (8) (1979) 1487-1491
31. Gibson R.S., Hess S.Y., Hotz C., and Brown K.H. Indicators of zinc status at the population level: a review of the evidence. Br J Nutr 99 June (Suppl. 3) (2008) S14-S23
32. Backstrom M., Shahabi V., Johansson S., Teneberg S., Kjellberg A., Miller-Podraza H., et al. Structural basis for differential receptor binding of cholera and Escherichia coli heat-labile toxins: influence of heterologous amino acid substitutions in the cholera B-subunit. Mol Microbiol 24 May (3) (1997) 489-497
33. Quiding M., Nordstrom I., Kilander A., Andersson G., Hanson L.A., Holmgren J., et al. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest 88 July (1) (1991) 143-148
34. Willems F., Vollstedt S., and Suter M. Phenotype and function of neonatal DC. Eur J Immunol 39 January (1) (2009) 26-35
35. Vekemans J., Amedei A., Ota M.O., D'Elios M.M., Goetghebuer T., Ismaili J., et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 31 May (5) (2001) 1531-1535
36. Amin P.B., Diebel L.N., and Liberati D.M. T-cell cytokines affect mucosal immunoglobulin A transport. Am J Surg 194 July (1) (2007) 128-133
37. Sollid L.M., Kvale D., Brandtzaeg P., Markussen G., and Thorsby E. Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol 138 June (12) (1987) 4303-4306
38. Brandtzaeg P., Bjerke K., Kett K., Kvale D., Rognum T.O., Scott H., et al. Production and secretion of immunoglobulins in the gastrointestinal tract. Ann Allergy 59 November (5 Pt 2) (1987) 21-39
39. Qadri F., Saha A., Ahmed T., Al Tarique A., Begum Y.A., and Svennerholm A.M. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 75 August (8) (2007) 3961-3968
40. Thiem V.D., Deen J.L., von Seidlein L., Canh do G., Anh D.D., Park J.K., et al. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine 24 May (20) (2006) 4297-4303
41. Fraker P.J., Jardieu P., and Cook J. Zinc deficiency and immune function. Arch Dermatol 123 December (12) (1987) 1699-1701
42. Prasad A.S. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 43 May (5) (2008) 370-377
43. Beck F.W., Prasad A.S., Kaplan J., Fitzgerald J.T., and Brewer G.J. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 272 June (6 Pt 1) (1997) E1002-E1007
44. Sandstead H.H., Prasad A.S., Penland J.G., Beck F.W., Kaplan J., Egger N.G., et al. Zinc deficiency in Mexican American children: influence of zinc and other micronutrients on T cells, cytokines, and antiinflammatory plasma proteins. Am J Clin Nutr 88 October (4) (2008) 1067-1073
45. Raqib R., Roy S.K., Rahman M.J., Azim T., Ameer S.S., Chisti J., et al. Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis. Am J Clin Nutr 79 March (3) (2004) 444-450
46. Schlesinger L., Arevalo M., Arredondo S., Diaz M., Lonnerdal B., and Stekel A. Effect of a zinc-fortified formula on immunocompetence and growth of malnourished infants. Am J Clin Nutr 56 September (3) (1992) 491-498
47. Kramer T.R., Udomkesmalee E., Dhanamitta S., Sirisinha S., Charoenkiatkul S., Tuntipopipat S., et al. Lymphocyte responsiveness of children supplemented with vitamin A and zinc. Am J Clin Nutr 58 October (4) (1993) 566-570
48. Osendarp S.J., Prabhakar H., Fuchs G.J., van Raaij J.M., Mahmud H., Tofail F., et al. Immunization with the heptavalent pneumococcal conjugate vaccine in Bangladeshi infants and effects of zinc supplementation. Vaccine 25 April (17) (2007) 3347-3354
49. Meydani A., Ahmed T., and Meydani S.N. Aging, nutritional status, and infection in the developing world. Nutr Rev 63 July (7) (2005) 233-246
50. Overbeck S., Rink L., and Haase H. Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch Immunol Ther Exp (Warsz) 56 January-February (1) (2008) 15-30
51. Karlsen T.H., Sommerfelt H., Klomstad S., Andersen P.K., Strand T.A., Ulvik R.J., et al. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation. Infect Immun 71 July (7) (2003) 3909-3913